Scientists have unveiled a breakthrough brain scan, the Cortical Disarray Measurement (CDM), which detects Alzheimer’s years before symptoms appear. Using advanced MRI analysis, CDM identifies microstructural brain changes early, enabling timely intervention. Backed by Oxford Brain Diagnostics, the FDA-designated tool could revolutionize dementia diagnosis and treatment.